Ausgabe 12/2022
Inhalt (28 Artikel)
A novel endoplasmic reticulum stress-related lncRNA prognostic risk model for cutaneous melanoma
- Original Article – Cancer Research
An-an Li, Fan Li, Min Lan, Yu Zhang, Dong Xie, Mei-ying Yan
Blocking autophagy with chloroquine aggravates lipid accumulation and reduces intracellular energy synthesis in hepatocellular carcinoma cells, both contributing to its anti-proliferative effect
- Open Access
- Original Article – Cancer Research
Fengming Xu, Hans-Michael Tautenhahn, Olaf Dirsch, Uta Dahmen
Aberrant MEK5 signalling promotes clear cell renal cell carcinoma development via mTOR activation
- Original Article – Cancer Research
Fangzhou Li, Xufeng Peng, Jiale Zhou, Qi Chen, Yonghui Chen
Single-cell transcriptional profiling reveals heterogeneity and developmental trajectories of Ewing sarcoma
- Original Article – Cancer Research
Bo Hong, Yi Li, Ran Yang, ShuYang Dai, Yong Zhan, Wen-Bo Zhang, Rui Dong
Inhibition of angiogenesis and tumor progression of MK-0429, an integrin αvβ3 antagonist, on oral squamous cell carcinoma
- Open Access
- Original Article – Cancer Research
Takayuki Nakagawa, Kouji Ohta, Takako Naruse, Miyuki Sakuma, Syohei Fukada, Nao Yamakado, Misaki Akagi, Kazuki Sasaki, Chieko Niwata, Shigehiro Ono, Tomonao Aikawa
CFTR reduces the proliferation of lung adenocarcinoma and is a strong predictor of survival in both smokers and non-smokers
- Open Access
- Original Article – Cancer Research
Qingyang Xiao, Stefania Koutsilieri, Despoina-Christina Sismanoglou, Volker M. Lauschke
Influencing factors of lung cancer patients' participation in shared decision-making: a cross-sectional study
- Original Article – Cancer Research
Ying Wang, Jinna Zhang, Bo Hu, Jizhe Wang, Laixiang Zhang, Xiaohua Li, Xiuli Zhu
Prognostic significance of MATR3 in stage I and II non-small cell lung cancer patients
- Original Article – Cancer Research
Justyna Durślewicz, Anna Klimaszewska-Wiśniewska, Jakub Jóźwicki, Paulina Antosik, Kamil Kozerawski, Dariusz Grzanka, Marcin Braun
Blood group antigens SLeX, SLeA, and LeY as prognostic markers in endometrial cancer
- Open Access
- Original Article – Cancer Research
Thomas Kolben, Lena Müller, Sarah Meister, Lucia Keilmann, Christina Buschmann, Fabian Trillsch, Alexander Burges, Bastian Czogalla, Sophie Mitter, Elisa Schmoeckel, Stefanie Corradini, Sven Mahner, Udo Jeschke, Mirjana Kessler, Susanne Beyer
Optimization of whole-cell vaccines with CpG/αOX40/cGAMP to strengthen the anti-tumor response of CD4+ T cells in melanomas
- Open Access
- Original Article – Cancer Research
Xuedan Du, Jinting Wu, Ye Zhao, Bin Wang, Xiaobo Ding, Qiuyan Lin, Yingyu Chen, Jinduo Zhao, Lixiao Liu, Xiaolu Mao, Zhen Fang, Chunhong Zhang, Wenfeng Li
Apalutamide and autophagy inhibition in a xenograft mouse model of human prostate cancer
- Open Access
- Original Article – Cancer Research
Daniel Eberli, Benedikt Kranzbühler, Lukas Prause, Valentin Baumgartner, Sheryl Preda, Rosa Sousa, Fabienne Lehner, Souzan Salemi
Synergistic antitumor effect of a penicillin derivative combined with thapsigargin in melanoma cells
- Original Article – Cancer Research
Yanina Bellizzi, Patricia G. Cornier, Carina M. L. Delpiccolo, Ernesto G. Mata, Viviana Blank, Leonor P. Roguin
N6-methyladenosine (m6A) reader IGF2BP2 stabilizes HK2 stability to accelerate the Warburg effect of oral squamous cell carcinoma progression
- Original Article – Cancer Research
Ke Xu, Xiaojuan Dai, Jiankun Wu, Kai Wen
Co-expression of DDR2 and IFITM1 promotes breast cancer cell proliferation, migration and invasion and inhibits apoptosis
- Original Article – Cancer Research
Chenlu Wu, Jiafei Ying, Mei Dai, Jing Peng, Danhua Zhang
The hyaluronan-related genes HAS2, HYAL1-4, PH20 and HYALP1 are associated with prognosis, cell viability and spheroid formation capacity in ovarian cancer
- Open Access
- Original Article – Cancer Research
Jette Riecks, Arianna Parnigoni, Balázs Győrffy, Ludwig Kiesel, Alberto Passi, Davide Vigetti, Martin Götte
T helper cell-mediated epitranscriptomic regulation via m6A RNA methylation bridges link between coronary artery disease and invasive ductal carcinoma
- Original Article – Cancer Research
Sudeshna Rakshit, Jithin S. Sunny, Melvin George, Luke Elizabeth Hanna, K. V. Leela, Koustav Sarkar
Prognostic impact of the number of peri-tumoral alveolar macrophages in patients with stage I lung adenocarcinoma
- Original Article – Cancer Research
Osamu Noritake, Keiju Aokage, Ayako Suzuki, Kenta Tane, Tomohiro Miyoshi, Joji Samejima, Toyohumi Yoshikawa, Shawhay Charles Murata, Tokiko Nakai, Masahiro Tsuboi, Genichiro Ishii
The clinical characteristics and prognostic factors of 410 patients with natural killer/T-cell lymphoma
- Original Article – Cancer Research
Zhenchang Sun, Wenjuan Wan, Xudong Zhang, Lei Zhang, Xin Li, Ling Li, Xinhua Wang, Feifei Nan, Hui Yu, Yu Chang, Jiaqin Yan, Zhaoming Li, Fangfang Cui, Jurui Ge, Yaqin Duo XiaXu, Xia Xu, Xiaorui Fu, Mingzhi Zhang
Clinical and sociodemographic determinants of disease-specific health-related quality of life in long-term breast cancer survivors
- Open Access
- Original Article – Cancer Research
Daniela Doege, Melissa S. Y. Thong, Lena Koch-Gallenkamp, Heike Bertram, Andrea Eberle, Bernd Holleczek, Alice Nennecke, Ron Pritzkuleit, Annika Waldmann, Sylke R. Zeissig, Hermann Brenner, Volker Arndt
Overexpression of splicing factor poly(rC)-binding protein 1 elicits cycle arrest, apoptosis induction, and p73 splicing in human cervical carcinoma cells
- Original Article – Cancer Research
Yuhong Chen, Zhihui Dou, Xiaohua Chen, Dapeng Zhao, Tuanjie Che, Wei Su, Tao Qu, Taotao Zhang, Caipeng Xu, Huiweng Lei, Qiang Li, Hong Zhang, Cuixia Di
Methyltransferase-like 3 facilitates lung cancer progression by accelerating m6A methylation-mediated primary miR-663 processing and impeding SOCS6 expression
- Original Article – Cancer Research
Shengshu Li, Xiaoxin Lu, Dongyang Zheng, Weizong Chen, Yuzhu Li, Fang Li
Modelling reoxygenation effects in non-small cell lung cancer cell lines and showing epithelial-mesenchymal transition
- Open Access
- Original Article – Cancer Research
Joanna Kapeleris, Juliana Müller Bark, Shanon Ranjit, Derek Richard, Ian Vela, Kenneth O’Byrne, Chamindie Punyadeera
Docetaxel enhances the therapeutic efficacy of PSMA-specific CAR-T cells against prostate cancer models by suppressing MDSCs
- Original Article – Cancer Research
Xiaokang Zhang, Shishuo Sun, Yangna Miao, Yifan Yuan, Wanxin Zhao, Hailong Li, Xiaohuan Wei, Chao Huang, Xiaolei Hu, Bixi Wang, Heng Xu, Wei Zhang, Xiaoge Gao, Jingyuan Song, Junnian Zheng, Qing Zhang
Combination of talazoparib and olaparib enhanced the curcumin-mediated apoptosis in oral cancer cells by PARP-1 trapping
- Original Article – Cancer Research
Subhajit Chatterjee, Ajit Kumar Dhal, Subarno Paul, Saptarshi Sinha, Biswajit Das, Somya Ranjan Dash, Chanakya Nath Kundu
The relationship between pan-immune-inflammation value and survival outcomes in patients with metastatic renal cell carcinoma treated with nivolumab in the second line and beyond: a Turkish oncology group kidney cancer consortium (TKCC) study
- Original Article – Clinical Oncology
Emre Yekedüz, Deniz Tural, İsmail Ertürk, Serdar Karakaya, Cihan Erol, Özlem Ercelep, Çağatay Arslan, Özlem Nuray Sever, Saadettin Kılıçkap, Nihan Şentürk Öztaş, Ahmet Küçükarda, Orçun Can, Berna Öksüzoğlu, Mehmet Ali Şendur, Nuri Karadurmuş, Yüksel Ürün
Atezolizumab combined with chemotherapy in the first-line treatment of extensive-stage small cell lung cancer: a real-life data of the Turkish Oncology Group
- Original Article – Clinical Oncology
Mustafa Gürbüz, Yasin Kutlu, Erman Akkuş, Elif Berna Köksoy, Naziyet Köse, Bala Başak Öven, Başak Oyan Uluç, Atike Gökçen Demiray, Dilek Erdem, Bilgin Demir, Nazım Serdar Turhal, Necdet Üskent, Sinem Akbaş, Fatih Selçukbiricik, Ali İnal, Ahmet Bilici, Ömer Fatih Ölmez, Devrim Çabuk, Çağlar Ünal, Mutlu Hızal, Mehmet Ali Nahit Şendur, Mustafa Korkmaz, Nuri Karadurmuş, İsmail Ertürk, Sema Sezgin Göksu, Ali Murat Tatlı, Deniz Can Güven, Saadettin Kılıçkap, Nail Paksoy, Adnan Aydıner, Havva Yeşil Çınkır, Özlem Özkul, Akın Öztürk, Sevinç Ballı, Yasemin Kemal, Atike Pınar Erdoğan, Özlem Er, Perran Fulden Yumuk, Ahmet Demirkazık
PD-1 inhibitors plus chemotherapy in EGFR/ALK-positive NSCLC patients with brain metastases and disease progression after EGFR/ALK-TKIs therapy
- Research
Yixiang Zhu, Ye Zhang, Xingsheng Hu, Mingzhao Wang, Hongyu Wang, Yutao Liu